Upstream Bio (UPB) Accounts Payables (2023 - 2026)

Upstream Bio's Accounts Payables history runs 4 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• In Q1 2026, Accounts Payables fell 63.76% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (down 63.76% YoY), while the FY2025 annual figure was $2.7 million, down 32.54% from the prior year.
• Accounts Payables was $1.7 million for Q1 2026 at Upstream Bio, down from $2.7 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $4.9 million in Q3 2024 to a low of $1.7 million in Q1 2026.
• Historically, Accounts Payables has averaged $3.3 million across 4 years, with a median of $3.3 million in 2025.
• The sharpest annual moves came in 2024 and 2026: Accounts Payables surged 103.07% in 2024, then tumbled 63.76% in 2026.
• A 4-year view of Accounts Payables shows it stood at $2.0 million in 2023, then jumped by 103.07% to $4.0 million in 2024, then sank by 32.54% to $2.7 million in 2025, then tumbled by 37.27% to $1.7 million in 2026.
• The last three Accounts Payables figures came in at $1.7 million (Q1 2026), $2.7 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.